Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.

about

Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.

Item

http://www.wikidata.org/entity/Q54940425

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@en

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@nl

type

Item

label

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@en

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@nl

prefLabel

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@en

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@nl

P1476

Inhibition of growth hormone r ...... reast cancer by 17β-estradiol.

@en

P2093

Carsten Gründker

http://www.w3.org/2001/XMLSchema#string

Günter Emons

http://www.w3.org/2001/XMLSchema#string

Rainer Girgert

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast

Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.

The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth.

Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol.

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.

Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers

Triple negative tumours: a critical review.

Growth hormone receptor modulators.

P304

9559-9566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8521

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29805678

http://www.w3.org/2001/XMLSchema#string

P932

5958647

http://www.w3.org/2001/XMLSchema#string